Indicators of adherence to antiretroviral therapy treatment among HIV/AIDS patients in 5 African countries

Journal of the International Association of Physicians in AIDS Care

Volumn 9, Issue 2, 2010, Pages 98-103

  Etienne, Martine ^b   Hossain, Mian ^a   Redfield, Robert ^b   Stafford, Kristen ^b   Amoroso, Anthony ^b  

^a MORGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Community; Indicators of adherence; Limited resources; Support

Indexed keywords

EFAVIRENZ; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; AGED; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; DEPRESSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

ADULT; AFRICA; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HEALTH CARE SURVEYS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; POVERTY; PROFESSIONAL-PATIENT RELATIONS; QUALITY OF LIFE; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 77953670020     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109710361383     Document Type: Article

References (19)

1. Celebrating Life: The U.S. President's Emergency Plan for AIDS Relief. 2009 Annual Report to Congress. Office of the United States Global AIDS Coordinator in collaboration with the United States Departments of State (including the United States Agency for International Development), Defense, Commerce, Labor, Health and Human Services (including the Centers for Disease Control and Prevention, the Food and Drug Administration, the Health Resources and Services Administration, the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, and the Office of Global Health Affairs), and the Peace Corps.
2. Tsasis P, Tsoukas C, Deutsch G. Evaluation of patient satisfaction in a specialized HIV/AIDS care unit of a major hospital. AIDS Patient Care STDS. 2000;14(7):347-349. doi:10.1089/108729100413211. (Pubitemid 30480376)
3. Beach MC, Keruly, Moore RD. Is the quality of the patientprovider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med. 2006; 21 (6): 661-665.
4. Bakken S, Holzemer WL, Brown MA, et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS. AIDS Patient Care STDS. 2000;14(4):189-197.
5. Wouters M. Outcome-based referral to improve quality of care in upper GI surgery. J Surg Oncol. 2008;98(5):307-308.
6. Fawole AO, Okunlola MA, Adekunle AO. Clients' perceptions of the quality of antenatal care. J Natl Med Assoc. 2008;100(9): 1052-1058.
7. Mfinanga SG, Kahwa A, Kimaro G, et al. Dissatisfaction with the laboratory services in conducting HIV related testing among public and private medical personnel in Tanzania. BMC Health Serv Res. 2008;8:171.
8. Sanjobo N, Frich JC, Fretheim A. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. Sahara J. 2008;5(3):136-143.
9. Morineau G, Vun MC, Barennes H, et al. Survival and Quality of Life Among HIV-Positive People on Antiretroviral Therapy in Cambodia. AIDS Patient Care STDS. 2009;23(8):669-677.
10. Protopopescu C, Raffi F, Roux P, et al., on behalf of the ANRS CO8 (APROCO-COPILOTE) Study Group. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the biase induced by missing data. J Antimicrob Chemother. 2009;64(3):599-606.
11. Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BioMed Central Public Health. 2008;8:265.
12. Poupard M, Ngom Gueye NF, Thiam D, et al. Quality of life and depression among HIV-infected patients receiving efavirenz-or protease inhibitor-based therapy in Senegal. HIV Med. 2007;8(2):92-95.
13. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160 (14): 2101-2107.
14. Weiser SD, Leiter K, Heisler M, et al. A population-based study on alcohol and high risk sexual behaviors in Botswana. PLOS Med. 2006;3(10):e392. Doi:10.1371/journal.pmed.0030392. (Pubitemid 44721833)
15. Carrieri MP, Leport C, Protopopescu C, et al. Factors associated with nonadherence to highly active antiretroviral therapy. A 5-year follow up analysis with correction for the bias induced by missing data in the treatment maintenance phase. Acquir Immune Defic Syndr. 2006;41(4):477-485.
16. Chipimo JP, Fylkesnes K. Mental distress in the general population in Zambia: impact of HIV and social factors. BMC Public Health. 2009;9:298. doi: 10.1186/1471-2458-9-298.
17. Byakika-Tusiime J, Crane J, Oyugi JH, et al. Longitudinal antire-troviral adherence in HIV+ Ugandan parents and their children initiating HAART inthe MTCT-Plus family treatment model:role of depression in declining adherence over time. AIDS Behav. 2009;13(suppl 1):82-91.
18. Boarts JM, Sledjeski EM, Bogart LM, Delahanty DL. The differential impact of PTSD and Depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS Behav. 2006;10(3):253-261.
19. Vlassova N, Angelino FA, TreismanGJ. Update onmental health issues in patients with HIV infection. Curr Infect Dis Rep. 2009; 11(2):163-169.